Possible Role of Everolimus in Improving Renal Function in Long-Term Heart Transplantation

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 1967-1969

  Fiocchi, R ^a   Iacovoni, A ^a   Sebastiani, R ^a   Fontana, A ^a   Gandolfi, L ^a   Gamba, A ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; EVEROLIMUS;

ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; LONG TERM CARE; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT;

CALCINEURIN; DRUG THERAPY, COMBINATION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; SIROLIMUS; SURVIVAL ANALYSIS;

EID: 34547566119     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.017     Document Type: Article

References (18)

1. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 4 (2003) 931
2. Myers B.D., Ross J., Newton L., et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 311 (1984) 699
3. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 28 (2003) 847
4. Kahan B.D., Kaplan B., Lorber M.I., et al. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection. Transplantation 71 (2001) 1400
5. Bohler T., Waiser J., Budde K., et al. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation. Transplant Proc 30 (1998) 2195
6. Boratynska M., Banasik M., Watorek E., et al. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 38 (2006) 101
7. Van den Akker J.M., Wetzels J.F., and Hoitsma A.J. Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. Kidney Int 70 (2006) 1355
8. Aliabadi A.Z., Kammerstatter D.P., Seebacher G., et al. Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients. Transplantation 15 (2006) 562
9. Schweiger M., Wasler A., Prenner G., et al. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients. Transpl Immunol 16 (2006) 46
10. Hummel M. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. J Heart Lung Transplant 24 (2005) 196
11. Bocchi E.A., Ahualli L., Amuchastegui M., et al. Recommendations for use of everolimus after heart transplantation: results from a Latin-American Consensus Meeting. Transplant Proc 38 (2006) 937
12. Lehmkuhl H., Ross H., Eisen H., et al. Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 37 (2005) 4145
13. Fiocchi R., Frigerio M., Parisi F., et al. Guidelines for everolimus introduction in stable heart transplant. Trapianti 3 (2006) 107
14. Groetzner J., Kaczmarek I., Meiser B., et al. Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure. J Heart Lung Transplant 23 (2004) 770
15. Hunt J., Lerman M., Magee M.J., et al. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation. J Heart Lung Transplant 24 (2005) 1863
16. Gleissner C.A., Doesch A., Ehlermann P., et al. Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy. Am J Transplant 6 (2006) 2750
17. Vazquez de Prada J.A., Vilchez F.G., Cobo M., et al. Sirolimus in de novo heart transplant recipients with severe renal impairment. Transpl Int 19 (2006) 245
18. Kovarik J.M., Dantal J., Civati G., et al. Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients. Am J Transplant 3 (2003) 1576